These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36526501)

  • 1. Assessing the pyrogenicity of whole influenza virus particle vaccine in cynomolgus macaques.
    Ohno M; Sagata M; Sekiya T; Nomura N; Shingai M; Endo M; Kimachi K; Suzuki S; Thanh Nguyen C; Nakayama M; Ishigaki H; Ogasawara K; Itoh Y; Kino Y; Kida H
    Vaccine; 2023 Jan; 41(3):787-794. PubMed ID: 36526501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with inactivated whole virus particle influenza virus vaccines improves the humoral response landscape in cynomolgus macaques.
    Chua BY; Sekiya T; Koutsakos M; Nomura N; Rowntree LC; Nguyen THO; McQuilten HA; Ohno M; Ohara Y; Nishimura T; Endo M; Itoh Y; Habel JR; Selva KJ; Wheatley AK; Wines BD; Hogarth PM; Kent SJ; Chung AW; Jackson DC; Brown LE; Shingai M; Kedzierska K; Kida H
    PLoS Pathog; 2022 Oct; 18(10):e1010891. PubMed ID: 36206307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent priming by inactivated whole influenza virus particle vaccines is linked to viral RNA uptake into antigen presenting cells.
    Shingai M; Nomura N; Sekiya T; Ohno M; Fujikura D; Handabile C; Omori R; Ohara Y; Nishimura T; Endo M; Kimachi K; Mitsumata R; Ikeda T; Kitayama H; Hatanaka H; Sobue T; Muro F; Suzuki S; Thanh Nguyen C; Ishigaki H; Nakayama M; Mori Y; Itoh Y; Koutsakos M; Chua BY; Kedzierska K; Brown LE; Jackson DC; Ogasawara K; Kino Y; Kida H
    Vaccine; 2021 Jun; 39(29):3940-3951. PubMed ID: 34090697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivated whole virus particle vaccine with potent immunogenicity and limited IL-6 induction is ideal for influenza.
    Sekiya T; Mifsud EJ; Ohno M; Nomura N; Sasada M; Fujikura D; Daito T; Shingai M; Ohara Y; Nishimura T; Endo M; Mitsumata R; Ikeda T; Hatanaka H; Kitayama H; Motokawa K; Sobue T; Suzuki S; Itoh Y; Brown LE; Ogasawara K; Kino Y; Kida H
    Vaccine; 2019 Apr; 37(15):2158-2166. PubMed ID: 30857932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivated whole influenza virus particle vaccines induce neutralizing antibodies with an increase in immunoglobulin gene subclones of B-lymphocytes in cynomolgus macaques.
    Shiohara M; Suzuki S; Shichinohe S; Ishigaki H; Nakayama M; Nomura N; Shingai M; Sekiya T; Ohno M; Iida S; Kawai N; Kawahara M; Yamagishi J; Ito K; Mitsumata R; Ikeda T; Motokawa K; Sobue T; Kida H; Ogasawara K; Itoh Y
    Vaccine; 2022 Jun; 40(30):4026-4037. PubMed ID: 35641357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivated Whole Virus Particle Influenza Vaccine Induces Anti-Neuraminidase Antibodies That May Contribute to Cross-Protection against Heterologous Virus Infection.
    Handabile C; Sekiya T; Nomura N; Ohno M; Kawakita T; Shingai M; Kida H
    Vaccines (Basel); 2022 May; 10(5):. PubMed ID: 35632561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against H5N1 highly pathogenic avian and pandemic (H1N1) 2009 influenza virus infection in cynomolgus monkeys by an inactivated H5N1 whole particle vaccine.
    Nakayama M; Shichinohe S; Itoh Y; Ishigaki H; Kitano M; Arikata M; Pham VL; Ishida H; Kitagawa N; Okamatsu M; Sakoda Y; Ichikawa T; Tsuchiya H; Nakamura S; Le QM; Ito M; Kawaoka Y; Kida H; Ogasawara K
    PLoS One; 2013; 8(12):e82740. PubMed ID: 24376571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and protective efficacy of a co-formulated two-in-one inactivated whole virus particle COVID-19/influenza vaccine.
    Handabile C; Ohno M; Sekiya T; Nomura N; Kawakita T; Kawahara M; Endo M; Nishimura T; Okumura M; Toba S; Sasaki M; Orba Y; Chua BY; Rowntree LC; Nguyen THO; Shingai M; Sato A; Sawa H; Ogasawara K; Kedzierska K; Kida H
    Sci Rep; 2024 Feb; 14(1):4204. PubMed ID: 38378856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memory immune responses against pandemic (H1N1) 2009 influenza virus induced by a whole particle vaccine in cynomolgus monkeys carrying Mafa-A1*052:02.
    Arikata M; Itoh Y; Okamatsu M; Maeda T; Shiina T; Tanaka K; Suzuki S; Nakayama M; Sakoda Y; Ishigaki H; Takada A; Ishida H; Soda K; Pham VL; Tsuchiya H; Nakamura S; Torii R; Shimizu T; Inoko H; Ohkubo I; Kida H; Ogasawara K
    PLoS One; 2012; 7(5):e37220. PubMed ID: 22623997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination against H9N2 avian influenza virus reduces bronchus-associated lymphoid tissue formation in cynomolgus macaques after intranasal virus challenge infection.
    Nakayama M; Ozaki H; Itoh Y; Soda K; Ishigaki H; Okamatsu M; Sakoda Y; Park CH; Tsuchiya H; Kida H; Ogasawara K
    Pathol Int; 2016 Dec; 66(12):678-686. PubMed ID: 27910264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous inoculation of a whole virus particle vaccine prepared from a non-pathogenic virus library induces protective immunity against H7N7 highly pathogenic avian influenza virus in cynomolgus macaques.
    Itoh Y; Ozaki H; Ishigaki H; Sakoda Y; Nagata T; Soda K; Isoda N; Miyake T; Ishida H; Okamoto K; Nakayama M; Tsuchiya H; Torii R; Kida H; Ogasawara K
    Vaccine; 2010 Jan; 28(3):780-9. PubMed ID: 19857455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivated influenza vaccine formulated with single-stranded RNA-based adjuvant confers mucosal immunity and cross-protection against influenza virus infection.
    Kim YH; Bang YJ; Park HJ; Li Ko H; Park SI; Hwang KA; Kim H; Nam JH
    Vaccine; 2020 Sep; 38(39):6141-6152. PubMed ID: 32739118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in children 6-59 months of age: A phase 3, randomized, noninferiority study.
    Statler VA; Albano FR; Airey J; Sawlwin DC; Graves Jones A; Matassa V; Heijnen E; Edelman J; Marshall GS
    Vaccine; 2019 Jan; 37(2):343-351. PubMed ID: 30057283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of the vaccine manufacturing process improves the pyrogenicity profile of inactivated influenza vaccines in young children.
    Sawlwin DC; Graves Jones A; Albano FR
    Vaccine; 2019 Apr; 37(18):2447-2454. PubMed ID: 30935743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential risk of repeated nasal vaccination that induces allergic reaction with mucosal IgE and airway eosinophilic infiltration in cynomolgus macaques infected with H5N1 highly pathogenic avian influenza virus.
    Nakayama M; Itoh Y; Shichinohe S; Nakabayashi R; Ishigaki H; Sakoda Y; Le QM; Kawaoka Y; Kida H; Ogasawara K
    Vaccine; 2017 Feb; 35(7):1008-1017. PubMed ID: 28109707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques.
    Itoh Y; Ozaki H; Tsuchiya H; Okamoto K; Torii R; Sakoda Y; Kawaoka Y; Ogasawara K; Kida H
    Vaccine; 2008 Jan; 26(4):562-72. PubMed ID: 18164788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemozoin is a potent adjuvant for hemagglutinin split vaccine without pyrogenicity in ferrets.
    Onishi M; Kitano M; Taniguchi K; Homma T; Kobayashi M; Sato A; Coban C; Ishii KJ
    Vaccine; 2014 May; 32(25):3004-9. PubMed ID: 24721532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of mucoadhesive excipient on the nasal retention time of and the antibody responses induced by an intranasal influenza vaccine.
    Saito S; Ainai A; Suzuki T; Harada N; Ami Y; Yuki Y; Takeyama H; Kiyono H; Tsukada H; Hasegawa H
    Vaccine; 2016 Feb; 34(9):1201-7. PubMed ID: 26802605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immune responses elicited by an intranasal inactivated H5 influenza vaccine.
    Ainai A; van Riet E; Ito R; Ikeda K; Senchi K; Suzuki T; Tamura SI; Asanuma H; Odagiri T; Tashiro M; Kurata T; Multihartina P; Setiawaty V; Pangesti KNA; Hasegawa H
    Microbiol Immunol; 2020 Apr; 64(4):313-325. PubMed ID: 31957054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity.
    Chua BY; Wong CY; Mifsud EJ; Edenborough KM; Sekiya T; Tan AC; Mercuri F; Rockman S; Chen W; Turner SJ; Doherty PC; Kelso A; Brown LE; Jackson DC
    mBio; 2015 Oct; 6(6):e01024-15. PubMed ID: 26507227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.